FIRVANQ KIT

Peak

vancomycin hydrochloride

NDAORALFOR SOLUTIONPriority Review

Approved

Jan 2018

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

[ see Microbiology ( ) ].

Indications (1)

enterocolitis caused by Staphylococcus aureus (including methicillin‑resistant strains) in adults

Loss of Exclusivity

LOE Date

Mar 13, 2035

109 months away

Patent Expiry

Mar 13, 2035

Patent Records (5)

Patent #	Expiry	Type	Use Code
10493028	Mar 13, 2035	Product	—
10688046	Mar 13, 2035	Product	—
10959946	Mar 13, 2035	Product	—
10959947	Mar 13, 2035	Product	U-3105
10959948	Mar 13, 2035	Product	U-3105

Company

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers